| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |